Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.Journal of the National Cancer Institute|September 4, 2009
Replication of prostate cancer risk loci in a Japanese case-control association studyHiroki Yamada, Kathryn L Penney, Hiroyuki Takahashi, et al.Journal of the National Cancer Institute|February 10, 2016
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7Masaki Shiota, Naohiro Fujimoto, Kenjiro Imada, et al.Prostate Cancer and Prostatic Diseases|October 8, 2025
Prognostic factors of PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysisTakafumi Yanagisawa, Akihiro Matsukawa, Paweł Rajwa, et al.Cancer Discovery|October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerJennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.Journal of Medicinal Chemistry|September 23, 2011
Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonistsChuangxing Guo, Angelica Linton, Susan Kephart, et al.EMBO Molecular Medicine|January 20, 2018
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1James W Peacock, Ario Takeuchi, Norihiro Hayashi, et al.Pageof 4